首页> 外文OA文献 >Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

【2h】

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

机译：量身定制的抗血小板治疗可以克服氯吡格雷和阿司匹林的抗药性-BOchum氯吡格雷和阿司匹林计划（BOCLA-Plan）可改善抗血小板治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Pepinghege Fenena; Lask Sebastian; Engelhardt Andreas; Krüger Jan C; Endres Heinz G; Kaiser Andreas FC; Neubauer Horst; Kusber Andreas; Mügge Andreas;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy [J] . Horst Neubauer, Andreas FC Kaiser, Heinz G Endres, BMC Medicine . 2011,第1期

机译：量身定制的抗血小板疗法可以克服氯吡格雷和阿司匹林抗性 - 波鸿氯吡格雷和阿司匹林计划（Bocla-plan）改善抗血小板治疗
2. Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI [J] . YangT.-H., JinH.-Y., ChoiK.-N., International Journal of Cardiology . 2013,第1期

机译：使用P2Y12即时检测在STEMI接受原发PCI的患者中对新的双重抗血小板疗法（阿司匹林，普拉格雷）和三重抗血小板疗法（阿司匹林，氯吡格雷，西洛他唑）进行随机比较
3. Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI [J] . YangT.-H., JinH.-Y., ChoiK.-N., International Journal of Cardiology . 2013,第1期

机译：用P2Y12接受初级PCI患者使用P2Y12护理点测定（Aspirin，Prasugrel）和三重抗血小板治疗（Aspirin，Prasugrel）和三重抗血小板治疗（Aspirin，Clopidogrel，Cilostazol）的随机比较
4. Inhibition of platelet aggregation by aspirin alone and by aspirin in combination with clopidogrel: synergy, incompatibility and additivity [C] . Helgason, C.M., Mordeson, Fuzzy Information Processing Society, 2000. NAFIPS. 19th International Conference of the North American . 2000

机译：单独使用阿司匹林或与阿司匹林联合氯吡格雷抑制血小板聚集：协同作用，不相容性和可加性
5. Antiplatelet activity to a high loading dose of clopidogrel quantified using point-of-care platelet aggregation assessment, is similar in diabetic versus non-diabetic patients [D] . Nathan, Sandeep 2008

机译：在糖尿病患者和非糖尿病患者中，通过即时护理血小板聚集评估定量的高剂量氯吡格雷抗血小板活性相似
6. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy [O] . Horst Neubauer, Andreas FC Kaiser, Heinz G Endres, 2011

机译：量身定制的抗血小板治疗可以克服氯吡格雷和阿司匹林的抗药性-BOchum氯吡格雷和阿司匹林计划（BOCLA-Plan）可改善抗血小板治疗
7. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy [O] . 2011

机译：量身定制的抗血小板治疗可以克服氯吡格雷和阿司匹林的抗药性-BOchum氯吡格雷和阿司匹林计划（BOCLA-Plan）可改善抗血小板治疗

Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - The BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy

著录项

引文网络

相似文献

相关主题

期刊订阅